Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation TCT 2017

RESOLVE/SAVORY: Topline Findings and Practice Implications

Presenter: David J. Moliterno, Vinod H. Thourani, Lars Sondergaard

November 01, 2017

Presentation TCT 2017

The PFO Clinic: Neurologists and Cardiologists as a Team

Presenter: Lee N. Benson, Megan Coylewright, Lars Sondergaard

November 01, 2017

Presentation TCT 2017

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Presenter: Martin B. Leon, Changfu Wu, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

Presenter: Peter C. Block, Lars Sondergaard, Armando Tellez, MD

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD

October 31, 2017

Presentation TCT 2017

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Presenter: Peter C. Block, Lars Sondergaard, Daniel J. Blackman

October 31, 2017

Presentation TCT 2017

The NOTION 2 Low-risk Trial in Younger Patients

Presenter: Lars Sondergaard

October 30, 2017

Presentation TCT 2017

Cerebral Protection During TAVR: Routine vs Selective Use

Presenter: David Hildick-Smith, Lars Sondergaard, Axel Linke

October 29, 2017

Presentation TCT 2017

LAA Closure: Underused Therapy in Patients With High Bleeding Risk

Presenter: David Hildick-Smith, Lars Sondergaard, Robert A. Byrne

October 29, 2017

Presentation TCT 2017

PFO Closure in Cryptogenic Stroke

Presenter: David Hildick-Smith, Lars Sondergaard

October 29, 2017

Presentation TCT 2017

Valve Thrombosis and Durability

Presenter: Jeroen J. Bax, Axel Linke, Lars Sondergaard

October 29, 2017

News Daily News

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Yael L. Maxwell

September 18, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

Presentation TVT 2017

Post TAVR Aortic Annulus Pseudoaneurysm (PSA)

Presenter: David W.M. Muller, Lars Sondergaard, Nicola Corvaja, MD

June 16, 2017

Presentation TVT 2017

TAVR Complicated by Ascending Aorta and Right Coronary Artery Dissection With Left Main Obstruction - When to Stop?

Presenter: David W.M. Muller, Lars Sondergaard, Marek Grygier, MD

June 16, 2017

Presentation TVT 2017

A Friendly Tie on a Hard TAVI

Presenter: David W.M. Muller, Lars Sondergaard, Roman Lezaun, MD

June 16, 2017

Presentation TVT 2017

Transulnar Primary PCI for Anterior STEMI After CoreValve Implantation

Presenter: David W.M. Muller, Lars Sondergaard, Sasko Kedev, MD

June 16, 2017

Presentation TVT 2017

Severe PVL, Caused by Ventricular Migration of Evolut R, Successfully Treated With Sapien-3 Valve-in-Valve

Presenter: David W.M. Muller, Lars Sondergaard, Peter den Heijer, MD

June 16, 2017

Advertisement

RESOLVE/SAVORY: Topline Findings and Practice Implications

The PFO Clinic: Neurologists and Cardiologists as a Team

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

The NOTION 2 Low-risk Trial in Younger Patients

Cerebral Protection During TAVR: Routine vs Selective Use

LAA Closure: Underused Therapy in Patients With High Bleeding Risk

PFO Closure in Cryptogenic Stroke

Valve Thrombosis and Durability

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Post TAVR Aortic Annulus Pseudoaneurysm (PSA)

TAVR Complicated by Ascending Aorta and Right Coronary Artery Dissection With Left Main Obstruction - When to Stop?

A Friendly Tie on a Hard TAVI

Transulnar Primary PCI for Anterior STEMI After CoreValve Implantation

Severe PVL, Caused by Ventricular Migration of Evolut R, Successfully Treated With Sapien-3 Valve-in-Valve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content